Weld Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Weld Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,186	Closed	-$213K	–	25
2021 Q2	$213K	Buy	+3,186	New	+$208K	0.22%	197
2020 Q4	–	Sell	-3,825	Closed	-$231K	–	482
2020 Q3	$231K	Sell	3,825 -44,056	-92%	-$2.65M	0.09%	349
2020 Q2	$2.81M	Buy	+47,881	New	+$2.86M	1.1%	1
2020 Q1	–	Sell	-7,021	Closed	-$451K	–	445
2019 Q4	$451K	Sell	7,021 -4,226	-38%	-$242K	0.09%	382
2019 Q3	$570K	Buy	11,247 +1,489	+15%	+$70K	0.1%	338
2019 Q2	$443K	Sell	9,758 -12,396	-56%	-$577K	0.08%	422
2019 Q1	$1.06M	Buy	22,154 +3,500	+19%	+$174K	0.19%	198
2018 Q4	$970K	Buy	+18,654	New	+$1M	0.22%	143

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Weld Capital Management's BMY Position: Q3 2021 in Review

Weld Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 3,186 shares — an estimated $213K sold.

Weld Capital Management first reported a position in BMY in Q4 2018 and held it in 8 quarters. The position peaked at $2.81M in Q2 2020. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Weld Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
Weld Capital Management sold 3,186 Bristol-Myers Squibb shares in Q3 2021, an estimated $213K.
Weld Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 8 quarters.
Weld Capital Management's Bristol-Myers Squibb position peaked at $2.81M in Q2 2020.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Weld Capital Management's 13F filing for Q3 2021.